TransCode Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 305.1%
Portfolio Pulse from Benzinga Newsdesk
Shares of TransCode Therapeutics were halted on a circuit breaker to the downside, despite the stock being up 305.1%.
September 25, 2023 | 2:47 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
TransCode Therapeutics, listed as RNAZ, saw its shares halted on a circuit breaker to the downside, even though the stock was up 305.1%.
The halt on TransCode Therapeutics shares due to a circuit breaker indicates a significant volatility in the stock. Despite this, the stock is up 305.1%, suggesting a strong bullish sentiment among investors. However, the halt could introduce uncertainty, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100